MarginsXMarginsX
Home › Markets › Health Care › MDLN

Medline Inc. (MDLN)

MDLN trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$39.17
-0.76% on the day
Market cap
$51.5B
Large cap
Revenue · 2025
$28.4B
+11.5% on 2024
Net income · 2025
$1.2B
4.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/0002046386-26-000009-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMDLN on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2025
SEC CIK0002046386
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$28.4B
Net income$1.2B
Operating income$2.2B
Net margin4.1%
Operating margin7.8%
Revenue growth+11.5%
Cash$1.9B
Total assets$38.5B
P/E (computed)44.5×
P/S (computed)1.8×

Warning signs

Cash runway
Cash-flow positive
$2.3B cash at September 26, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$6.7B
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$2.3B cash; operating cash flow $595.3M a quarter.Report 2026-09-26
Shares outstanding1,315,321,434 (2026-11-02).Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Chicago, Illinois, United StatesPCAOB Form AP 2026-03-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $515.0M, sold $7.2B on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-26
$7.9B$318.0M$1.0B$2.3B$12.6B$30.7B10-Q 2026-11-04
Q2 2026
2026-06-27
$7.7B$139.0M$715.0M$2.3B$12.6B$29.9B10-Q 2026-08-05
Q1 2026
2026-03-28
$7.4B$239.0M$412.0M$2.2B$12.6B$29.1B10-Q 2026-05-06
Q4 2025
2025-12-31
$7.8B$193.0M$229.0M$1.9B$12.6B$28.4B10-K 2026-02-25
Q3 2025
2025-09-27
$7.1B$318.0M$636.0M$955.0MNo debt tagsNeeds four quarters10-Q 2026-11-04
Q2 2025
2025-06-28
$6.9B$329.0M$197.0M$584.0MNo debt tagsNeeds four quarters10-Q 2026-08-05
Q1 2025
2025-03-29
$6.6B$319.0M$682.0M$840.0MNo debt tagsNeeds four quarters10-Q 2026-05-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12026-11-16
Latest annual report10-K2026-02-25
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-23

Source: SEC EDGAR submissions feed, 168 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-0.4%
1 month+10.6%
3 months+10.9%
Year to date-6.0%
1 yearNot enough price history
From 52-week high-21.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
BDXBecton Dickinson and Company$216.47-0.72%$59.0B
BSXBoston Scientific Corporation$43.69-1.47%$63.3B
RMDResMed Inc.$238.19-0.56%$33.5B
DXCMDexCom Inc.$81.61-2.06%$30.4B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B
MMM3M Company$181.68-1.08%$93.9B
SYKStryker Corporation$310.72+0.35%$118.3B
SOLVSolventum Corporation$88.65-0.48%$15.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier